RNAi Therapeutics Market is projected to grow at an annualized rate of ~45%, till 2030

Market-Research

Roots Analysis has done a detailed study on RNAi Therapeutics Market (2nd Edition), 2019 - 2030: Focus on siRNA, miRNA, shRNA and DNA ... Read more

Submitted by Roots_Analysis on 2021-01-08 08:33.

RNAi Therapeutics Market is estimated to be worth USD 9.2 billion in 2030, predicts Roots Analysis

Market-Research

The potential therapeutic applications of RNAi were realized almost immediately after the phenomenon was first described; over the years, developers have gradually progressed their proprietary drug candidates with cautious optimism

Submitted by Roots_Analysis on 2021-01-08 08:32.

The RNAi therapeutics market is anticipated to grow at an annualized rate of more than 45%, till 2030, claims Roots Analysis

Market-Research

The recent approval of first RNAi therapeutic, ONPATTRO^TM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological research

London ... Read more

Submitted by Roots_Analysis on 2021-01-08 08:31.

Biopharmaceutical Contract Manufacturing Market (3rd edition), 2019 – 2030” report features an extensive study on the contract service providers within the biopharmaceutical industry.

Pharmaceuticals

To order this 750+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2021-01-07 09:39.

Over 235 companies worldwide claim to offer contract manufacturing services for various types of biopharmaceutical drug / therapy products

Pharmaceuticals

Owing to the ever-increasing number of start-ups that are involved in R&D of novel biologics, there is an enormous opportunity for the CMOs in this domain. It is worth emphasizing that, since 2000, more than 115 new CMOs have been established in order to serve to the growing demand for novel ... Read more

Submitted by Roots_Analysis on 2021-01-07 09:38.

The biopharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~8%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Biopharma Contract ... Read more

Submitted by Roots_Analysis on 2021-01-07 09:37.

The biopharmaceutical contract manufacturing market is estimated to be worth USD 13.9 billion in 2030, predicts Roots Analysis

Pharmaceuticals

Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages

Submitted by Roots_Analysis on 2021-01-07 09:36.

Biologics Fill / Finish Service Providers, 2019-2030

Pharmaceuticals

To order this detailed 480+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2021-01-07 09:35.

Over 115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharmaceutical drug / therapy products, claims Roots Analysis

Pharmaceuticals

Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations. Consequently, a number of drug manufacturers have

Submitted by Roots_Analysis on 2021-01-07 09:35.

The contract fill / finish services market for biologics market is projected to grow at an annualized rate of ~10%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Biologics Fill / Finish Services Market, 2019-2030, covering key aspects of the ... Read more

Submitted by Roots_Analysis on 2021-01-07 09:34.

The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030, predicts Roots Analysis

Pharmaceuticals

A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety

Roots Analysis ... Read more

Submitted by Roots_Analysis on 2021-01-07 09:33.

More than 100 subcutaneous biologics have been approved and over 350 such drug candidates are being evaluated in the clinical stages of development, for the treatment of a wide variety of disease indications, claims Roots Analysis

Pharmaceuticals

Several approved therapeutic products, which are currently available as intravenous dosage forms, are being reformulated and evaluated for subcutaneous administration. Further, many existing drug delivery devices, including prefilled syringes, pen injectors, autoinjectors, needle-free injectors ... Read more

Submitted by Roots_Analysis on 2021-01-06 09:55.

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030

Market-Research

Roots Analysis has done a detailed report on Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), ... Read more

Submitted by Roots_Analysis on 2021-01-06 09:54.

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis

Market-Research

Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals

Submitted by Roots_Analysis on 2021-01-06 09:53.

STING Pathway Targeting Therapeutics and Technologies, 2020-2030” report features an extensive study of the current market landscape and future potential of these therapeutics and affiliated technologies, over the next decade.

Market-Research

To order this detailed 310+ page report, please visit this link

Key Inclusions ... Read more

Submitted by Roots_Analysis on 2021-01-06 09:52.

Many small / macro molecule-based STING pathway modulators are currently being evaluated as monotherapies as well as in combination with other drugs, claims Roots Analysis

Market-Research

In recent years, the concept of STING pathway targeting therapeutics has generated a lot of enthusiasm within the medical science community. The growing popularity of this therapeutic technique has not only garnered the interest of several medical researchers (reflected in the increasing ... Read more

Submitted by Roots_Analysis on 2021-01-06 09:52.

The STING pathway targeting technologies market is projected to grow at an annualized rate of ~25%, till 2030

Market-Research

Roots Analysis has done a detailed study on STING Pathway targeting therapeutics and Technologies, 2020-2030, covering key ... Read more

Submitted by Roots_Analysis on 2021-01-06 09:51.

The STING pathway targeting technologies market, featuring a healthy pipeline of therapeutics, is anticipated to be worth over USD 2.8 billion by 2030, predicts Roots Analysis

Pharmaceuticals

STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being pursued by several large pharmaceutical companies

Submitted by Roots_Analysis on 2021-01-06 09:50.

The “Targeted Protein Degradation Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics and affiliated technologies, over the next decade.

Market-Research

To order this 330+ page report, please visit this link

Key Inclusions

A detailed assessment of the

Submitted by Roots_Analysis on 2021-01-05 09:38.

More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are over 25 technology platforms available for use in therapy development efforts

Market-Research

The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was developed about a decade ... Read more

Submitted by Roots_Analysis on 2021-01-05 09:37.

Pages